The natural history of de novo donor-specific HLA antibodies after kidney transplantation

• Covadonga López del Moral,
• Covadonga López del Moral,
• Kaiyin Wu,
• Marcel Naik,
• Bilgin Osmanodja,
• Aylin Akifova,
• Nils Lachmann,
• Diana Stauch,
• Sabine Hergovits,
• Mira Choi,
• Friederike Bachmann,
• Fabian Halleck,
• Eva Schrezenmeier,
• Eva Schrezenmeier,
• Danilo Schmidt,
• Klemens Budde

Affiliations

Covadonga López del Moral

Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Covadonga López del Moral

Valdecilla Biomedical Research Institute (IDIVAL), Santander, Spain

Kaiyin Wu

Department of Pathology, Charité – Universitätsmedizin Berlin, Berlin, Germany

Marcel Naik

Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Bilgin Osmanodja

Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Aylin Akifova

Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Nils Lachmann

Institute for Transfusion Medicine, HLA-Laboratory, Charité – Universitätsmedizin Berlin, Berlin, Germany

Diana Stauch

Institute for Transfusion Medicine, HLA-Laboratory, Charité – Universitätsmedizin Berlin, Berlin, Germany

Sabine Hergovits

Institute for Transfusion Medicine, HLA-Laboratory, Charité – Universitätsmedizin Berlin, Berlin, Germany

Mira Choi

Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Friederike Bachmann

Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Fabian Halleck

Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Eva Schrezenmeier

Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Eva Schrezenmeier

Berlin Institute of Health Charité – Universitätsmedizin Berlin, BIH Academy, Berlin, Germany

Danilo Schmidt

Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany

Klemens Budde

Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany